Document Type

Conference Proceeding

Publication Date

9-1-2021

Publication Title

J Am Acad Dermatol

Abstract

Introduction: Hidradenitis suppurativa (HS) is often refractory to medical and surgical interventions. Carbon dioxide (CO2) laser excision has demonstrated promising results for HS treatment.

Objective: We characterized the efficacy and safety of CO2 laser excision for HS in smokers and diabetics.

Methods: On initial data pull, 72 patients were identified. This number was reduced to 38 patients by including HS patients with all data points at Henry Ford Hospital who underwent CO2 laser excision between August 2014 to May 2017. Data were obtained from medical charts including healing and recurrence rates, complications, smoking status, and history of diabetes mellitus.

Results: The average age of our cohort was 37.5 years and mean BMI was 34.9. In total, 3 patients had recurrence at a mean of 6 months following the procedure. Postoperative complications included: infection (n = 2), contracture (n = 2), dehiscence (n = 2), and paresthesia (n = 1). Patients with dehiscence were not smokers or diabetics. Twelve patients were smokers, and 26 patients were nonsmokers. The mean healing time in both smokers and nonsmokers was 6 months. Nine patients had a history of diabetes mellitus (DM), and 29 patients were not diabetic. The mean healing time was not significantly prolonged in diabetics compared to nondiabetics and was 7.3 months and 5.4 months, respectively.

Conclusion: Both smokers and nonsmokers demonstrated similar healing time, recurrence rates, and postoperative complications. Patients with DM had prolonged healing times when compared to those without DM. Our study identifies important characteristics that clinicians should consider when assessing HS patients for CO2 laser excision.

Volume

85

Issue

3

First Page

AB25

Share

COinS